Wedbush Securities’s Strata Skin Sciences SSKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-362
Closed -$11K 868
2017
Q1
$11K Hold
362
﹤0.01% 834
2016
Q4
$8K Hold
362
﹤0.01% 813
2016
Q3
$10K Hold
362
﹤0.01% 824
2016
Q2
$11K Sell
362
-10
-3% -$402 ﹤0.01% 778
2016
Q1
$18K Sell
372
-20
-5% -$1.03K ﹤0.01% 732
2015
Q4
$22K Buy
+392
New +$22.4K ﹤0.01% 715
2015
Q3
Sell
-249
Closed -$14K 768
2015
Q2
$14K Buy
+249
New +$20.3K ﹤0.01% 717
2014
Q3
Sell
-137
Closed -$22K 717
2014
Q2
$22K Hold
137
﹤0.01% 649
2014
Q1
$43K Hold
137
0.01% 611
2013
Q4
$44K Buy
137
+16
+13% +$5.73K 0.01% 566
2013
Q3
$44K Buy
121
+4
+3% +$1.6K 0.01% 546
2013
Q2
$54K Buy
+117
New +$62.7K 0.01% 513

Other funds holding SSKN

Wedbush Securities's SSKN Position: Q2 2017 in Review

Wedbush Securities sold out of Strata Skin Sciences (SSKN) in Q2 2017, closing a stake of 362 shares — an estimated $11K sold.

Wedbush Securities first reported a position in SSKN in Q2 2013 and held it in 12 quarters. The position peaked at $54K in Q2 2013. 18 funds tracked by Wall St. Rank hold SSKN as of Q2 2017.

  • Wedbush Securities reported no remaining Strata Skin Sciences position as of Q2 2017 after selling out during the quarter.
  • Wedbush Securities sold 362 Strata Skin Sciences shares in Q2 2017, an estimated $11K.
  • Wedbush Securities first reported a position in Strata Skin Sciences in Q2 2013 and held it in 12 quarters.
  • Wedbush Securities's Strata Skin Sciences position peaked at $54K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2017.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.